2
Key Points
➤ The goal of this guideline is to improve the quality of care and treatment
outcomes for patients with eating disorders, as defined by the Diagnostic
and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision
(DSM-5-TR; American Psychiatric Association 2013).
➤ We focus primarily on anorexia nervosa (AN), bulimia nervosa (BN),
and binge-eating disorder (BED) rather than other feeding and eating
disorders.
➤ The lifetime prevalence of eating disorders in the United States is
approximately 0.80% for AN, 0.28% for BN, and 0.85% for BED.
➤ The lifetime burdens and psychosocial impairments associated with an
eating disorder can be substantial because these illnesses typically have
an onset in adolescence or early adulthood and can persist for decades.
➤ Eating disorders are associated with increases in all-cause mortality and
deaths due to suicide.
➤ Morbidity and mortality among individuals with an eating disorder are
heightened by the common co-occurrence of health conditions, such
as diabetes, and other psychiatric disorders, particularly depression,
anxiety, posttraumatic stress disorder (PTSD), obsessive-compulsive
disorder (OCD), attention-deficit/hyperactivity disorder (ADHD), and
substance use disorders.
➤ This guideline is intended to enhance the assessment and treatment
of eating disorders, thereby reducing the mortality, morbidity, and
significant psychosocial and health consequences of these important
psychiatric conditions.
